Selected research
Industry Research
Pemetrexed Disodium for Injection Industry Research Report 2026
Market perspective
The global Pemetrexed Disodium for Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pemetrexed Disodium for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pemetrexed Disodium for Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pemetrexed Disodium for Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pemetrexed Disodium for Injection include Accord Healthcare, Amneal Pharmaceuticals, APOTEX, Biocon, Dr. Reddy's Laboratories, Eugia Pharma, Nang Kuang Pharmaceutical, Pfizer (Hospira) and Waverley Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pemetrexed Disodium for Injection market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pemetrexed Disodium for Injection Market by Company
Accord Healthcare
Amneal Pharmaceuticals
APOTEX
Biocon
Dr. Reddy's Laboratories
Eugia Pharma
Nang Kuang Pharmaceutical
Pfizer (Hospira)
Waverley Pharma
Zydus Lifesciences
Baxter
Beijing Xiehe Pharmaceutical
Dezhou Deyao Pharmaceutical
Fresenius Kabi
Hainan Jinrui Pharmaceutical
Kelun Pharmaceutical
Jiangsu Aosaikang Pharmaceutical
Qilu Pharmaceutical
Lilly
Lianyungang Jaripharm Pharmaceutical
Nanjing Pharmaceutical Factory
Jiangsu Hansoh Pharmaceutical
Sandoz
Zhendong Group
Shanghai Chemo Wanbang Biopharma
Sichuan Huiyu Pharmaceutical
Suzhou Erye Pharmaceutical
Suzhou Thery Pharmaceutical
Jiangsu Simcere Pharmaceutical
Yangtze River Pharmaceutical Group
Pemetrexed Disodium for Injection Segment by Type
500mg/Pcs
100mg/Pcs
Pemetrexed Disodium for Injection Segment by Application
Hospitals
Clinics
Others
Pemetrexed Disodium for Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pemetrexed Disodium for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pemetrexed Disodium for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pemetrexed Disodium for Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pemetrexed Disodium for Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pemetrexed Disodium for Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pemetrexed Disodium for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Pemetrexed Disodium for Injection Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Pemetrexed Disodium for Injection Sales (k units) of Manufacturers (2021-2026)
Table 7. Global Pemetrexed Disodium for Injection Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Pemetrexed Disodium for Injection Revenue of Manufacturers (2021-2026)
Table 9. Global Pemetrexed Disodium for Injection Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Pemetrexed Disodium for Injection Average Price (US$/unit) of Manufacturers (2021-2026)
Table 11. Global Pemetrexed Disodium for Injection Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Pemetrexed Disodium for Injection, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Pemetrexed Disodium for Injection, Product Type & Application
Table 14. Global Pemetrexed Disodium for Injection Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Pemetrexed Disodium for Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Accord Healthcare Company Information
Table 19. Accord Healthcare Business Overview
Table 20. Accord Healthcare Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 21. Accord Healthcare Pemetrexed Disodium for Injection Product Portfolio
Table 22. Accord Healthcare Recent Developments
Table 23. Amneal Pharmaceuticals Company Information
Table 24. Amneal Pharmaceuticals Business Overview
Table 25. Amneal Pharmaceuticals Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 26. Amneal Pharmaceuticals Pemetrexed Disodium for Injection Product Portfolio
Table 27. Amneal Pharmaceuticals Recent Developments
Table 28. APOTEX Company Information
Table 29. APOTEX Business Overview
Table 30. APOTEX Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 31. APOTEX Pemetrexed Disodium for Injection Product Portfolio
Table 32. APOTEX Recent Developments
Table 33. Biocon Company Information
Table 34. Biocon Business Overview
Table 35. Biocon Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 36. Biocon Pemetrexed Disodium for Injection Product Portfolio
Table 37. Biocon Recent Developments
Table 38. Dr. Reddy's Laboratories Company Information
Table 39. Dr. Reddy's Laboratories Business Overview
Table 40. Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 41. Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Product Portfolio
Table 42. Dr. Reddy's Laboratories Recent Developments
Table 43. Eugia Pharma Company Information
Table 44. Eugia Pharma Business Overview
Table 45. Eugia Pharma Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 46. Eugia Pharma Pemetrexed Disodium for Injection Product Portfolio
Table 47. Eugia Pharma Recent Developments
Table 48. Nang Kuang Pharmaceutical Company Information
Table 49. Nang Kuang Pharmaceutical Business Overview
Table 50. Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 51. Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
Table 52. Nang Kuang Pharmaceutical Recent Developments
Table 53. Pfizer (Hospira) Company Information
Table 54. Pfizer (Hospira) Business Overview
Table 55. Pfizer (Hospira) Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 56. Pfizer (Hospira) Pemetrexed Disodium for Injection Product Portfolio
Table 57. Pfizer (Hospira) Recent Developments
Table 58. Waverley Pharma Company Information
Table 59. Waverley Pharma Business Overview
Table 60. Waverley Pharma Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 61. Waverley Pharma Pemetrexed Disodium for Injection Product Portfolio
Table 62. Waverley Pharma Recent Developments
Table 63. Zydus Lifesciences Company Information
Table 64. Zydus Lifesciences Business Overview
Table 65. Zydus Lifesciences Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 66. Zydus Lifesciences Pemetrexed Disodium for Injection Product Portfolio
Table 67. Zydus Lifesciences Recent Developments
Table 68. Baxter Company Information
Table 69. Baxter Business Overview
Table 70. Baxter Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 71. Baxter Pemetrexed Disodium for Injection Product Portfolio
Table 72. Baxter Recent Developments
Table 73. Beijing Xiehe Pharmaceutical Company Information
Table 74. Beijing Xiehe Pharmaceutical Business Overview
Table 75. Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 76. Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
Table 77. Beijing Xiehe Pharmaceutical Recent Developments
Table 78. Dezhou Deyao Pharmaceutical Company Information
Table 79. Dezhou Deyao Pharmaceutical Business Overview
Table 80. Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 81. Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
Table 82. Dezhou Deyao Pharmaceutical Recent Developments
Table 83. Fresenius Kabi Company Information
Table 84. Fresenius Kabi Business Overview
Table 85. Fresenius Kabi Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 86. Fresenius Kabi Pemetrexed Disodium for Injection Product Portfolio
Table 87. Fresenius Kabi Recent Developments
Table 88. Hainan Jinrui Pharmaceutical Company Information
Table 89. Hainan Jinrui Pharmaceutical Business Overview
Table 90. Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 91. Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
Table 92. Hainan Jinrui Pharmaceutical Recent Developments
Table 93. Kelun Pharmaceutical Company Information
Table 94. Kelun Pharmaceutical Business Overview
Table 95. Kelun Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 96. Kelun Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
Table 97. Kelun Pharmaceutical Recent Developments
Table 98. Jiangsu Aosaikang Pharmaceutical Company Information
Table 99. Jiangsu Aosaikang Pharmaceutical Business Overview
Table 100. Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 101. Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
Table 102. Jiangsu Aosaikang Pharmaceutical Recent Developments
Table 103. Qilu Pharmaceutical Company Information
Table 104. Qilu Pharmaceutical Business Overview
Table 105. Qilu Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 106. Qilu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
Table 107. Qilu Pharmaceutical Recent Developments
Table 108. Lilly Company Information
Table 109. Lilly Business Overview
Table 110. Lilly Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 111. Lilly Pemetrexed Disodium for Injection Product Portfolio
Table 112. Lilly Recent Developments
Table 113. Lianyungang Jaripharm Pharmaceutical Company Information
Table 114. Lianyungang Jaripharm Pharmaceutical Business Overview
Table 115. Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 116. Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
Table 117. Lianyungang Jaripharm Pharmaceutical Recent Developments
Table 118. Nanjing Pharmaceutical Factory Company Information
Table 119. Nanjing Pharmaceutical Factory Business Overview
Table 120. Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 121. Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Product Portfolio
Table 122. Nanjing Pharmaceutical Factory Recent Developments
Table 123. Jiangsu Hansoh Pharmaceutical Company Information
Table 124. Jiangsu Hansoh Pharmaceutical Business Overview
Table 125. Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 126. Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
Table 127. Jiangsu Hansoh Pharmaceutical Recent Developments
Table 128. Sandoz Company Information
Table 129. Sandoz Business Overview
Table 130. Sandoz Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 131. Sandoz Pemetrexed Disodium for Injection Product Portfolio
Table 132. Sandoz Recent Developments
Table 133. Zhendong Group Company Information
Table 134. Zhendong Group Business Overview
Table 135. Zhendong Group Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 136. Zhendong Group Pemetrexed Disodium for Injection Product Portfolio
Table 137. Zhendong Group Recent Developments
Table 138. Shanghai Chemo Wanbang Biopharma Company Information
Table 139. Shanghai Chemo Wanbang Biopharma Business Overview
Table 140. Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 141. Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Product Portfolio
Table 142. Shanghai Chemo Wanbang Biopharma Recent Developments
Table 143. Sichuan Huiyu Pharmaceutical Company Information
Table 144. Sichuan Huiyu Pharmaceutical Business Overview
Table 145. Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 146. Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
Table 147. Sichuan Huiyu Pharmaceutical Recent Developments
Table 148. Suzhou Erye Pharmaceutical Company Information
Table 149. Suzhou Erye Pharmaceutical Business Overview
Table 150. Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 151. Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
Table 152. Suzhou Erye Pharmaceutical Recent Developments
Table 153. Suzhou Thery Pharmaceutical Company Information
Table 154. Suzhou Thery Pharmaceutical Business Overview
Table 155. Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 156. Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
Table 157. Suzhou Thery Pharmaceutical Recent Developments
Table 158. Jiangsu Simcere Pharmaceutical Company Information
Table 159. Jiangsu Simcere Pharmaceutical Business Overview
Table 160. Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 161. Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
Table 162. Jiangsu Simcere Pharmaceutical Recent Developments
Table 163. Yangtze River Pharmaceutical Group Company Information
Table 164. Yangtze River Pharmaceutical Group Business Overview
Table 165. Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 166. Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Product Portfolio
Table 167. Yangtze River Pharmaceutical Group Recent Developments
Table 168. Global Pemetrexed Disodium for Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 169. Global Pemetrexed Disodium for Injection Sales by Region (2021-2026) & (k units)
Table 170. Global Pemetrexed Disodium for Injection Sales Market Share by Region (2021-2026)
Table 171. Global Pemetrexed Disodium for Injection Sales by Region (2027-2032) & (k units)
Table 172. Global Pemetrexed Disodium for Injection Sales Market Share by Region (2027-2032)
Table 173. Global Pemetrexed Disodium for Injection Revenue by Region (2021-2026) & (US$ Million)
Table 174. Global Pemetrexed Disodium for Injection Revenue Market Share by Region (2021-2026)
Table 175. Global Pemetrexed Disodium for Injection Revenue by Region (2027-2032) & (US$ Million)
Table 176. Global Pemetrexed Disodium for Injection Revenue Market Share by Region (2027-2032)
Table 177. North America Pemetrexed Disodium for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 178. North America Pemetrexed Disodium for Injection Sales by Country (2021-2026) & (k units)
Table 179. North America Pemetrexed Disodium for Injection Sales by Country (2027-2032) & (k units)
Table 180. North America Pemetrexed Disodium for Injection Revenue by Country (2021-2026) & (US$ Million)
Table 181. North America Pemetrexed Disodium for Injection Revenue by Country (2027-2032) & (US$ Million)
Table 182. Europe Pemetrexed Disodium for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 183. Europe Pemetrexed Disodium for Injection Sales by Country (2021-2026) & (k units)
Table 184. Europe Pemetrexed Disodium for Injection Sales by Country (2027-2032) & (k units)
Table 185. Europe Pemetrexed Disodium for Injection Revenue by Country (2021-2026) & (US$ Million)
Table 186. Europe Pemetrexed Disodium for Injection Revenue by Country (2027-2032) & (US$ Million)
Table 187. Asia Pacific Pemetrexed Disodium for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 188. Asia Pacific Pemetrexed Disodium for Injection Sales by Country (2021-2026) & (k units)
Table 189. Asia Pacific Pemetrexed Disodium for Injection Sales by Country (2027-2032) & (k units)
Table 190. Asia Pacific Pemetrexed Disodium for Injection Revenue by Country (2021-2026) & (US$ Million)
Table 191. Asia Pacific Pemetrexed Disodium for Injection Revenue by Country (2027-2032) & (US$ Million)
Table 192. South America Pemetrexed Disodium for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 193. South America Pemetrexed Disodium for Injection Sales by Country (2021-2026) & (k units)
Table 194. South America Pemetrexed Disodium for Injection Sales by Country (2027-2032) & (k units)
Table 195. South America Pemetrexed Disodium for Injection Revenue by Country (2021-2026) & (US$ Million)
Table 196. South America Pemetrexed Disodium for Injection Revenue by Country (2027-2032) & (US$ Million)
Table 197. Middle East and Africa Pemetrexed Disodium for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 198. Middle East and Africa Pemetrexed Disodium for Injection Sales by Country (2021-2026) & (k units)
Table 199. Middle East and Africa Pemetrexed Disodium for Injection Sales by Country (2027-2032) & (k units)
Table 200. Middle East and Africa Pemetrexed Disodium for Injection Revenue by Country (2021-2026) & (US$ Million)
Table 201. Middle East and Africa Pemetrexed Disodium for Injection Revenue by Country (2027-2032) & (US$ Million)
Table 202. Global Pemetrexed Disodium for Injection Sales by Type (2021-2026) & (k units)
Table 203. Global Pemetrexed Disodium for Injection Sales by Type (2027-2032) & (k units)
Table 204. Global Pemetrexed Disodium for Injection Sales Market Share by Type (2021-2026)
Table 205. Global Pemetrexed Disodium for Injection Sales Market Share by Type (2027-2032)
Table 206. Global Pemetrexed Disodium for Injection Revenue by Type (2021-2026) & (US$ Million)
Table 207. Global Pemetrexed Disodium for Injection Revenue by Type (2027-2032) & (US$ Million)
Table 208. Global Pemetrexed Disodium for Injection Revenue Market Share by Type (2021-2026)
Table 209. Global Pemetrexed Disodium for Injection Revenue Market Share by Type (2027-2032)
Table 210. Global Pemetrexed Disodium for Injection Price by Type (2021-2026) & (US$/unit)
Table 211. Global Pemetrexed Disodium for Injection Price by Type (2027-2032) & (US$/unit)
Table 212. Global Pemetrexed Disodium for Injection Sales by Application (2021-2026) & (k units)
Table 213. Global Pemetrexed Disodium for Injection Sales by Application (2027-2032) & (k units)
Table 214. Global Pemetrexed Disodium for Injection Sales Market Share by Application (2021-2026)
Table 215. Global Pemetrexed Disodium for Injection Sales Market Share by Application (2027-2032)
Table 216. Global Pemetrexed Disodium for Injection Revenue by Application (2021-2026) & (US$ Million)
Table 217. Global Pemetrexed Disodium for Injection Revenue by Application (2027-2032) & (US$ Million)
Table 218. Global Pemetrexed Disodium for Injection Revenue Market Share by Application (2021-2026)
Table 219. Global Pemetrexed Disodium for Injection Revenue Market Share by Application (2027-2032)
Table 220. Global Pemetrexed Disodium for Injection Price by Application (2021-2026) & (US$/unit)
Table 221. Global Pemetrexed Disodium for Injection Price by Application (2027-2032) & (US$/unit)
Table 222. Key Raw Materials
Table 223. Raw Materials Key Suppliers
Table 224. Pemetrexed Disodium for Injection Distributors List
Table 225. Pemetrexed Disodium for Injection Customers List
Table 226. Pemetrexed Disodium for Injection Industry Trends
Table 227. Pemetrexed Disodium for Injection Industry Drivers
Table 228. Pemetrexed Disodium for Injection Industry Restraints
Table 229. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Pemetrexed Disodium for Injection Product Image
Figure 5. Global Pemetrexed Disodium for Injection Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Pemetrexed Disodium for Injection Market Size (2021-2032) & (US$ Million)
Figure 7. Global Pemetrexed Disodium for Injection Sales (2021-2032) & (k units)
Figure 8. Global Pemetrexed Disodium for Injection Average Price (US$/unit) & (2021-2032)
Figure 9. 500mg/Pcs Product Image
Figure 10. 100mg/Pcs Product Image
Figure 11. Hospitals Product Image
Figure 12. Clinics Product Image
Figure 13. Others Product Image
Figure 14. Global Pemetrexed Disodium for Injection Revenue Share by Manufacturers in 2025
Figure 15. Global Manufacturers of Pemetrexed Disodium for Injection, Manufacturing Sites & Headquarters
Figure 16. Global Top 5 and 10 Pemetrexed Disodium for Injection Players Market Share by Revenue in 2025
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 18. Global Pemetrexed Disodium for Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 19. Global Pemetrexed Disodium for Injection Sales by Region in 2025
Figure 20. Global Pemetrexed Disodium for Injection Revenue by Region in 2025
Figure 21. North America Pemetrexed Disodium for Injection Market Size by Country in 2025
Figure 22. North America Pemetrexed Disodium for Injection Sales Market Share by Country (2021-2032)
Figure 23. North America Pemetrexed Disodium for Injection Revenue Market Share by Country (2021-2032)
Figure 24. United States Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 25. Canada Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Mexico Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Europe Pemetrexed Disodium for Injection Market Size by Country in 2025
Figure 28. Europe Pemetrexed Disodium for Injection Sales Market Share by Country (2021-2032)
Figure 29. Europe Pemetrexed Disodium for Injection Revenue Market Share by Country (2021-2032)
Figure 30. Germany Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. France Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. U.K. Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. Italy Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Russia Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Spain Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Netherlands Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Switzerland Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Sweden Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Poland Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Asia Pacific Pemetrexed Disodium for Injection Market Size by Country in 2025
Figure 41. Asia Pacific Pemetrexed Disodium for Injection Sales Market Share by Country (2021-2032)
Figure 42. Asia Pacific Pemetrexed Disodium for Injection Revenue Market Share by Country (2021-2032)
Figure 43. China Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. Japan Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. South Korea Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. India Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. Australia Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. Taiwan Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Southeast Asia Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Southeast Asia Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. South America Pemetrexed Disodium for Injection Market Size by Country in 2025
Figure 52. South America Pemetrexed Disodium for Injection Sales Market Share by Country (2021-2032)
Figure 53. South America Pemetrexed Disodium for Injection Revenue Market Share by Country (2021-2032)
Figure 54. Brazil Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 55. Argentina Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Chile Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Middle East and Africa Pemetrexed Disodium for Injection Market Size by Country in 2025
Figure 58. Middle East and Africa Pemetrexed Disodium for Injection Sales Market Share by Country (2021-2032)
Figure 59. Middle East and Africa Pemetrexed Disodium for Injection Revenue Market Share by Country (2021-2032)
Figure 60. Egypt Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 61. South Africa Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 62. Israel Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. Türkiye Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. GCC Countries Pemetrexed Disodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 65. Global Pemetrexed Disodium for Injection Sales Market Share by Type (2021-2032)
Figure 66. Global Pemetrexed Disodium for Injection Revenue Market Share by Type (2021-2032)
Figure 67. Global Pemetrexed Disodium for Injection Price (US$/unit) by Type (2021-2032)
Figure 68. Global Pemetrexed Disodium for Injection Sales Market Share by Application (2021-2032)
Figure 69. Global Pemetrexed Disodium for Injection Revenue Market Share by Application (2021-2032)
Figure 70. Global Pemetrexed Disodium for Injection Price (US$/unit) by Application (2021-2032)
Figure 71. Pemetrexed Disodium for Injection Value Chain
Figure 72. Pemetrexed Disodium for Injection Production Mode & Process
Figure 73. Direct Comparison with Distribution Share
Figure 74. Distributors Profiles
Figure 75. Pemetrexed Disodium for Injection Industry Opportunities and Challenges
Scope & coverage.
Types
- 500mg/Pcs
- 100mg/Pcs
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Accord Healthcare
- Amneal Pharmaceuticals
- APOTEX
- Biocon
- Dr. Reddy's Laboratories
- Eugia Pharma
- Nang Kuang Pharmaceutical
- Pfizer (Hospira)
- Waverley Pharma
- Zydus Lifesciences
- Baxter
- Beijing Xiehe Pharmaceutical
- Dezhou Deyao Pharmaceutical
- Fresenius Kabi
- Hainan Jinrui Pharmaceutical
- Kelun Pharmaceutical
- Jiangsu Aosaikang Pharmaceutical
- Qilu Pharmaceutical
- Lilly
- Lianyungang Jaripharm Pharmaceutical
- Nanjing Pharmaceutical Factory
- Jiangsu Hansoh Pharmaceutical
- Sandoz
- Zhendong Group
- Shanghai Chemo Wanbang Biopharma
- Sichuan Huiyu Pharmaceutical
- Suzhou Erye Pharmaceutical
- Suzhou Thery Pharmaceutical
- Jiangsu Simcere Pharmaceutical
- Yangtze River Pharmaceutical Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pemetrexed Disodium for Injection Market Size (2021-2032)
- 2.2.2 Global Pemetrexed Disodium for Injection Sales (2021-2032)
- 2.2.3 Global Pemetrexed Disodium for Injection Market Average Price (2021-2032)
- 2.3 Pemetrexed Disodium for Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 500mg/Pcs
- 2.3.3 100mg/Pcs
- 2.4 Pemetrexed Disodium for Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinics
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pemetrexed Disodium for Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pemetrexed Disodium for Injection Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Pemetrexed Disodium for Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Pemetrexed Disodium for Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Pemetrexed Disodium for Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pemetrexed Disodium for Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pemetrexed Disodium for Injection, Product Type & Application
- 3.8 Global Manufacturers of Pemetrexed Disodium for Injection, Established Date
- 3.9 Global Pemetrexed Disodium for Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Accord Healthcare
- 4.1.1 Accord Healthcare Company Information
- 4.1.2 Accord Healthcare Business Overview
- 4.1.3 Accord Healthcare Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Accord Healthcare Pemetrexed Disodium for Injection Product Portfolio
- 4.1.5 Accord Healthcare Recent Developments
- 4.2 Amneal Pharmaceuticals
- 4.2.1 Amneal Pharmaceuticals Company Information
- 4.2.2 Amneal Pharmaceuticals Business Overview
- 4.2.3 Amneal Pharmaceuticals Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Amneal Pharmaceuticals Pemetrexed Disodium for Injection Product Portfolio
- 4.2.5 Amneal Pharmaceuticals Recent Developments
- 4.3 APOTEX
- 4.3.1 APOTEX Company Information
- 4.3.2 APOTEX Business Overview
- 4.3.3 APOTEX Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 APOTEX Pemetrexed Disodium for Injection Product Portfolio
- 4.3.5 APOTEX Recent Developments
- 4.4 Biocon
- 4.4.1 Biocon Company Information
- 4.4.2 Biocon Business Overview
- 4.4.3 Biocon Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Biocon Pemetrexed Disodium for Injection Product Portfolio
- 4.4.5 Biocon Recent Developments
- 4.5 Dr. Reddy's Laboratories
- 4.5.1 Dr. Reddy's Laboratories Company Information
- 4.5.2 Dr. Reddy's Laboratories Business Overview
- 4.5.3 Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Product Portfolio
- 4.5.5 Dr. Reddy's Laboratories Recent Developments
- 4.6 Eugia Pharma
- 4.6.1 Eugia Pharma Company Information
- 4.6.2 Eugia Pharma Business Overview
- 4.6.3 Eugia Pharma Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Eugia Pharma Pemetrexed Disodium for Injection Product Portfolio
- 4.6.5 Eugia Pharma Recent Developments
- 4.7 Nang Kuang Pharmaceutical
- 4.7.1 Nang Kuang Pharmaceutical Company Information
- 4.7.2 Nang Kuang Pharmaceutical Business Overview
- 4.7.3 Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
- 4.7.5 Nang Kuang Pharmaceutical Recent Developments
- 4.8 Pfizer (Hospira)
- 4.8.1 Pfizer (Hospira) Company Information
- 4.8.2 Pfizer (Hospira) Business Overview
- 4.8.3 Pfizer (Hospira) Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Pfizer (Hospira) Pemetrexed Disodium for Injection Product Portfolio
- 4.8.5 Pfizer (Hospira) Recent Developments
- 4.9 Waverley Pharma
- 4.9.1 Waverley Pharma Company Information
- 4.9.2 Waverley Pharma Business Overview
- 4.9.3 Waverley Pharma Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Waverley Pharma Pemetrexed Disodium for Injection Product Portfolio
- 4.9.5 Waverley Pharma Recent Developments
- 4.10 Zydus Lifesciences
- 4.10.1 Zydus Lifesciences Company Information
- 4.10.2 Zydus Lifesciences Business Overview
- 4.10.3 Zydus Lifesciences Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Zydus Lifesciences Pemetrexed Disodium for Injection Product Portfolio
- 4.10.5 Zydus Lifesciences Recent Developments
- 4.11 Baxter
- 4.11.1 Baxter Company Information
- 4.11.2 Baxter Business Overview
- 4.11.3 Baxter Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Baxter Pemetrexed Disodium for Injection Product Portfolio
- 4.11.5 Baxter Recent Developments
- 4.12 Beijing Xiehe Pharmaceutical
- 4.12.1 Beijing Xiehe Pharmaceutical Company Information
- 4.12.2 Beijing Xiehe Pharmaceutical Business Overview
- 4.12.3 Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
- 4.12.5 Beijing Xiehe Pharmaceutical Recent Developments
- 4.13 Dezhou Deyao Pharmaceutical
- 4.13.1 Dezhou Deyao Pharmaceutical Company Information
- 4.13.2 Dezhou Deyao Pharmaceutical Business Overview
- 4.13.3 Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
- 4.13.5 Dezhou Deyao Pharmaceutical Recent Developments
- 4.14 Fresenius Kabi
- 4.14.1 Fresenius Kabi Company Information
- 4.14.2 Fresenius Kabi Business Overview
- 4.14.3 Fresenius Kabi Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Fresenius Kabi Pemetrexed Disodium for Injection Product Portfolio
- 4.14.5 Fresenius Kabi Recent Developments
- 4.15 Hainan Jinrui Pharmaceutical
- 4.15.1 Hainan Jinrui Pharmaceutical Company Information
- 4.15.2 Hainan Jinrui Pharmaceutical Business Overview
- 4.15.3 Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
- 4.15.5 Hainan Jinrui Pharmaceutical Recent Developments
- 4.16 Kelun Pharmaceutical
- 4.16.1 Kelun Pharmaceutical Company Information
- 4.16.2 Kelun Pharmaceutical Business Overview
- 4.16.3 Kelun Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Kelun Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
- 4.16.5 Kelun Pharmaceutical Recent Developments
- 4.17 Jiangsu Aosaikang Pharmaceutical
- 4.17.1 Jiangsu Aosaikang Pharmaceutical Company Information
- 4.17.2 Jiangsu Aosaikang Pharmaceutical Business Overview
- 4.17.3 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
- 4.17.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
- 4.18 Qilu Pharmaceutical
- 4.18.1 Qilu Pharmaceutical Company Information
- 4.18.2 Qilu Pharmaceutical Business Overview
- 4.18.3 Qilu Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Qilu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
- 4.18.5 Qilu Pharmaceutical Recent Developments
- 4.19 Lilly
- 4.19.1 Lilly Company Information
- 4.19.2 Lilly Business Overview
- 4.19.3 Lilly Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Lilly Pemetrexed Disodium for Injection Product Portfolio
- 4.19.5 Lilly Recent Developments
- 4.20 Lianyungang Jaripharm Pharmaceutical
- 4.20.1 Lianyungang Jaripharm Pharmaceutical Company Information
- 4.20.2 Lianyungang Jaripharm Pharmaceutical Business Overview
- 4.20.3 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
- 4.20.5 Lianyungang Jaripharm Pharmaceutical Recent Developments
- 4.21 Nanjing Pharmaceutical Factory
- 4.21.1 Nanjing Pharmaceutical Factory Company Information
- 4.21.2 Nanjing Pharmaceutical Factory Business Overview
- 4.21.3 Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.21.4 Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Product Portfolio
- 4.21.5 Nanjing Pharmaceutical Factory Recent Developments
- 4.22 Jiangsu Hansoh Pharmaceutical
- 4.22.1 Jiangsu Hansoh Pharmaceutical Company Information
- 4.22.2 Jiangsu Hansoh Pharmaceutical Business Overview
- 4.22.3 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.22.4 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
- 4.22.5 Jiangsu Hansoh Pharmaceutical Recent Developments
- 4.23 Sandoz
- 4.23.1 Sandoz Company Information
- 4.23.2 Sandoz Business Overview
- 4.23.3 Sandoz Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.23.4 Sandoz Pemetrexed Disodium for Injection Product Portfolio
- 4.23.5 Sandoz Recent Developments
- 4.24 Zhendong Group
- 4.24.1 Zhendong Group Company Information
- 4.24.2 Zhendong Group Business Overview
- 4.24.3 Zhendong Group Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.24.4 Zhendong Group Pemetrexed Disodium for Injection Product Portfolio
- 4.24.5 Zhendong Group Recent Developments
- 4.25 Shanghai Chemo Wanbang Biopharma
- 4.25.1 Shanghai Chemo Wanbang Biopharma Company Information
- 4.25.2 Shanghai Chemo Wanbang Biopharma Business Overview
- 4.25.3 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.25.4 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Product Portfolio
- 4.25.5 Shanghai Chemo Wanbang Biopharma Recent Developments
- 4.26 Sichuan Huiyu Pharmaceutical
- 4.26.1 Sichuan Huiyu Pharmaceutical Company Information
- 4.26.2 Sichuan Huiyu Pharmaceutical Business Overview
- 4.26.3 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.26.4 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
- 4.26.5 Sichuan Huiyu Pharmaceutical Recent Developments
- 4.27 Suzhou Erye Pharmaceutical
- 4.27.1 Suzhou Erye Pharmaceutical Company Information
- 4.27.2 Suzhou Erye Pharmaceutical Business Overview
- 4.27.3 Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.27.4 Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
- 4.27.5 Suzhou Erye Pharmaceutical Recent Developments
- 4.28 Suzhou Thery Pharmaceutical
- 4.28.1 Suzhou Thery Pharmaceutical Company Information
- 4.28.2 Suzhou Thery Pharmaceutical Business Overview
- 4.28.3 Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.28.4 Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
- 4.28.5 Suzhou Thery Pharmaceutical Recent Developments
- 4.29 Jiangsu Simcere Pharmaceutical
- 4.29.1 Jiangsu Simcere Pharmaceutical Company Information
- 4.29.2 Jiangsu Simcere Pharmaceutical Business Overview
- 4.29.3 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.29.4 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
- 4.29.5 Jiangsu Simcere Pharmaceutical Recent Developments
- 4.30 Yangtze River Pharmaceutical Group
- 4.30.1 Yangtze River Pharmaceutical Group Company Information
- 4.30.2 Yangtze River Pharmaceutical Group Business Overview
- 4.30.3 Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.30.4 Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Product Portfolio
- 4.30.5 Yangtze River Pharmaceutical Group Recent Developments
5 Global Pemetrexed Disodium for Injection Market Scenario by Region
- 5.1 Global Pemetrexed Disodium for Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pemetrexed Disodium for Injection Sales by Region: 2021-2032
- 5.2.1 Global Pemetrexed Disodium for Injection Sales by Region: 2021-2026
- 5.2.2 Global Pemetrexed Disodium for Injection Sales by Region: 2027-2032
- 5.3 Global Pemetrexed Disodium for Injection Revenue by Region: 2021-2032
- 5.3.1 Global Pemetrexed Disodium for Injection Revenue by Region: 2021-2026
- 5.3.2 Global Pemetrexed Disodium for Injection Revenue by Region: 2027-2032
- 5.4 North America Pemetrexed Disodium for Injection Market Facts & Figures by Country
- 5.4.1 North America Pemetrexed Disodium for Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pemetrexed Disodium for Injection Sales by Country (2021-2032)
- 5.4.3 North America Pemetrexed Disodium for Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Pemetrexed Disodium for Injection Market Facts & Figures by Country
- 5.5.1 Europe Pemetrexed Disodium for Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pemetrexed Disodium for Injection Sales by Country (2021-2032)
- 5.5.3 Europe Pemetrexed Disodium for Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Pemetrexed Disodium for Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pemetrexed Disodium for Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pemetrexed Disodium for Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pemetrexed Disodium for Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pemetrexed Disodium for Injection Market Facts & Figures by Country
- 5.7.1 South America Pemetrexed Disodium for Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pemetrexed Disodium for Injection Sales by Country (2021-2032)
- 5.7.3 South America Pemetrexed Disodium for Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Pemetrexed Disodium for Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pemetrexed Disodium for Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pemetrexed Disodium for Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pemetrexed Disodium for Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Pemetrexed Disodium for Injection Sales by Type (2021-2032)
- 6.1.1 Global Pemetrexed Disodium for Injection Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Pemetrexed Disodium for Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Pemetrexed Disodium for Injection Revenue by Type (2021-2032)
- 6.2.1 Global Pemetrexed Disodium for Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pemetrexed Disodium for Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Pemetrexed Disodium for Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pemetrexed Disodium for Injection Sales by Application (2021-2032)
- 7.1.1 Global Pemetrexed Disodium for Injection Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Pemetrexed Disodium for Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Pemetrexed Disodium for Injection Revenue by Application (2021-2032)
- 7.2.1 Global Pemetrexed Disodium for Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pemetrexed Disodium for Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Pemetrexed Disodium for Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pemetrexed Disodium for Injection Value Chain Analysis
- 8.1.1 Pemetrexed Disodium for Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pemetrexed Disodium for Injection Production Mode & Process
- 8.2 Pemetrexed Disodium for Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pemetrexed Disodium for Injection Distributors
- 8.2.3 Pemetrexed Disodium for Injection Customers
9 Global Pemetrexed Disodium for Injection Analyzing Market Dynamics
- 9.1 Pemetrexed Disodium for Injection Industry Trends
- 9.2 Pemetrexed Disodium for Injection Industry Drivers
- 9.3 Pemetrexed Disodium for Injection Industry Opportunities and Challenges
- 9.4 Pemetrexed Disodium for Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst